Viral microRNA regulation of Akt is necessary for reactivation of Human Cytomegalovirus from latency in CD34+ hematopoietic progenitor cells and humanized mice

被引:0
|
作者
Diggins, Nicole L. [1 ]
Pham, Andrew H. [1 ]
Mitchell, Jennifer [1 ]
Parkins, Christopher J. [1 ]
Slind, Luke [1 ]
Turner, Rebekah [1 ]
Lee, Byeong-Jae [2 ]
Yurochko, Andrew D. [2 ]
Caposio, Patrizia [1 ]
Nelson, Jay A. [1 ]
Hancock, Meaghan H. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA
[2] Louisiana State Univ, Ctr Appl Immunol & Pathol Proc, Ctr Emerging Viral Threats, Dept Microbiol & Immunol,Hlth Sci Ctr Shreveport, Shreveport, LA USA
关键词
PHOSPHATIDYLINOSITOL; 3-KINASE; MONOCYTE DIFFERENTIATION; PI3K/AKT PATHWAY; GENE-EXPRESSION; MESSENGER-RNA; STEM-CELL; ACTIVATION; INFECTION; PROMOTES; SURVIVAL;
D O I
10.1371/journal.ppat.1012285
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human cytomegalovirus (HCMV) actively manipulates cellular signaling pathways to benefit viral replication. Phosphatidyl-inositol 3-kinase (PI3K)/Akt signaling is an important negative regulator of HCMV replication, and during lytic infection the virus utilizes pUL38 to limit Akt phosphorylation and activity. During latency, PI3K/Akt signaling also limits virus replication, but how this is overcome at the time of reactivation is unknown. Virally encoded microRNAs (miRNAs) are a key component of the virus arsenal used to alter signaling during latency and reactivation. In the present study we show that three HCMV miRNAs (miR-UL36, miR-UL112 and miR-UL148D) downregulate Akt expression and attenuate downstream signaling, resulting in the activation of FOXO3a and enhanced internal promoter-driven IE transcription. A virus lacking expression of all three miRNAs is unable to reactivate from latency both in CD34+ hematopoietic progenitor cells and in a humanized mouse model of HCMV infection, however downregulating Akt restores the ability of the mutant virus to replicate. These findings highlight the negative role Akt signaling plays in HCMV replication in lytic and latent infection and how the virus has evolved miRNA-mediated countermeasures to promote successful reactivation.
引用
收藏
页数:33
相关论文
共 50 条
  • [1] Human Cytomegalovirus US28 Ligand Binding Activity Is Required for Latency in CD34+ Hematopoietic Progenitor Cells and Humanized NSG Mice
    Crawford, Lindsey B.
    Caposio, Patrizia
    Kreklywich, Craig
    Pham, Andrew H.
    Hancock, Meaghan H.
    Jones, Taylor A.
    Smith, Patricia P.
    Yurochko, Andrew D.
    Nelson, Jay A.
    Streblow, Daniel N.
    MBIO, 2019, 10 (04):
  • [2] Human Cytomegalovirus Enters the Primary CD34+ Hematopoietic Progenitor Cells Where It Establishes Latency by Macropinocytosis
    Lee, Jeong-Hee
    Kalejta, Robert F.
    JOURNAL OF VIROLOGY, 2019, 93 (15)
  • [3] Human Cytomegalovirus Infection Suppresses CD34+ Progenitor Cell Engraftment in Humanized Mice
    Crawford, Lindsey B.
    Tempel, Rebecca
    Streblow, Daniel N.
    Yurochko, Andrew D.
    Goodrum, Felicia D.
    Nelson, Jay A.
    Caposio, Patrizia
    MICROORGANISMS, 2020, 8 (04)
  • [4] Human Cytomegalovirus miRNAs Regulate TGF-β to Mediate Myelosuppression while Maintaining Viral Latency in CD34+ Hematopoietic Progenitor Cells
    Hancock, Meaghan H.
    Crawford, Lindsey B.
    Pham, Andrew H.
    Mitchell, Jennifer
    Struthers, Hillary M.
    Yurochko, Andrew D.
    Caposio, Patrizia
    Nelson, Jay A.
    CELL HOST & MICROBE, 2020, 27 (01) : 104 - +
  • [5] DETECTION OF CYTOMEGALOVIRUS DNA IN CD34+ HEMATOPOIETIC PROGENITOR CELLS
    VONLAER, D
    MEYERKOENIG, U
    SERR, A
    FINKE, J
    FAUSER, AA
    NEUMANNHAEFELIN, D
    BRUGGER, W
    HUFERT, FT
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 867 - 867
  • [6] Cellular and Viral Control over the Initial Events of Human Cytomegalovirus Experimental Latency in CD34+ Cells
    Saffert, Ryan T.
    Penkert, Rhiannon R.
    Kalejta, Robert F.
    JOURNAL OF VIROLOGY, 2010, 84 (11) : 5594 - 5604
  • [7] The transcriptome of human CD34+ hematopoietic stem-progenitor cells
    Kim, Yeong C.
    Wu, Qingfa
    Chen, Jun
    Xuan, Zhenyu
    Jung, Yong-Chul
    Zhang, Michael Q.
    Rowley, Janet D.
    Wang, San Ming
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (20) : 8278 - 8283
  • [8] Dendritic cell differentiation from hematopoietic CD34+ progenitor cells
    Curti, A
    Fogli, M
    Ratta, M
    Biasco, G
    Tura, S
    Lemoli, RM
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2001, 15 (01): : 49 - 52
  • [9] Histopathology and Biodistribution in NCG Mice Engrafted with Mobilized CD34+ Human Hematopoietic Stem and Progenitor Cells
    Smutova, Viktorija
    Moreno, Angela Holguin
    Gains, Malcolm
    Para, Camila
    Spickler, Catherine
    Riffon, Renee
    Hung, Selly
    Rowe, Jenny
    Festin, Steve
    Authier, Simon
    Hoberman, Alan M.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2023, 42 (01) : 92 - 92
  • [10] EX-VIVO EXPANSION OF HUMAN CD34+ HEMATOPOIETIC PROGENITOR CELLS
    FEL, R
    HEIMFELD, S
    XU, Z
    FOGARTY, B
    JONES, HM
    THOMPSON, P
    BERENSON, RJ
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 726 - 726